Colon cancer patients who have the normal version of a particular gene are more likely to benefit from a combination treatment that includes adding the targeted therapy Erbitux to chemotherapy. Read the rest of this entry »
Jun
4
Erbitux Works Well for Two-Thirds of Colon Cancer Patients
genetic |
Articles, Biochemistry, Cancer, Clinical Trials, Drug Trials, News, Oncology |
06 4th, 2008|
No Comments »
Jun
4
Avastin Added to Chemo Helps Women With Advanced Cancer
genetic |
Articles, Biochemistry, Cancer, Clinical Research, Clinical Trials, Drug Discovery, Drug Trials, News, Oncology |
06 4th, 2008|
No Comments »
Adding the drug Avastin to chemotherapy lengthened progression-free survival in women with advanced breast cancer, new research shows. Read the rest of this entry »